These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39019421)

  • 1. Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis.
    Lam L; Soret PA; Lemoinne S; Hansen B; Hirschfield G; Gulamhusein A; Montano-Loza AJ; Lytvyak E; Parés A; Olivas I; Londono MC; Rodríguez-Tajes S; Eaton JE; Osman KT; Schramm C; Sebode M; Lohse AW; Dalekos G; Gatselis N; Nevens F; Cazzagon N; Zago A; Russo FP; Floreani A; Abbas N; Trivedi P; Thorburn D; Saffioti F; Barkai L; Roccarina D; Calvaruso V; Fichera A; Delamarre A; Sobenko N; Villamil AM; Medina-Morales E; Bonder A; Patwardhan V; Rigamonti C; Carbone M; Invernizzi P; Cristoferi L; van der Meer A; de Veer R; Zigmond E; Yehezkel E; Kremer AE; Deibel A; Bruns T; Große K; Wetten A; Dyson JK; Jones D; Levy C; Tanaka A; Dumortier J; Pageaux GP; de Lédinghen V; Carrat F; Chazouillères O; Corpechot C;
    Clin Gastroenterol Hepatol; 2024 Dec; 22(12):2432-2441.e2. PubMed ID: 39019421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.
    Corpechot C; Carrat F; Gaouar F; Chau F; Hirschfield G; Gulamhusein A; Montano-Loza AJ; Lytvyak E; Schramm C; Pares A; Olivas I; Eaton JE; Osman KT; Dalekos G; Gatselis N; Nevens F; Cazzagon N; Zago A; Russo FP; Abbas N; Trivedi P; Thorburn D; Saffioti F; Barkai L; Roccarina D; Calvaruso V; Fichera A; Delamarre A; Medina-Morales E; Bonder A; Patwardhan V; Rigamonti C; Carbone M; Invernizzi P; Cristoferi L; van der Meer A; de Veer R; Zigmond E; Yehezkel E; Kremer AE; Deibel A; Dumortier J; Bruns T; Große K; Pageaux GP; Wetten A; Dyson J; Jones D; Chazouillères O; Hansen B; de Lédinghen V;
    J Hepatol; 2022 Dec; 77(6):1545-1553. PubMed ID: 35777587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria.
    Ding D; Guo G; Cui L; Jia G; Wang X; Zhang M; Tian S; Zheng L; Liu Y; Hu Y; Xuan G; Yang J; Yang C; Sun R; Deng J; Guo C; Chen Y; Shang Y; Han Y
    Hepatol Int; 2024 Feb; 18(1):206-215. PubMed ID: 37725332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
    Harms MH; van Buuren HR; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Hirschfield GM; Parés A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Lammers WJ; Hansen BE; van der Meer AJ
    J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.
    Joshita S; Yamashita Y; Sugiura A; Uehara T; Usami Y; Yamazaki T; Fujimori N; Matsumoto A; Tanaka E; Umemura T
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1208-1214. PubMed ID: 31724755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
    Wu HM; Sheng L; Wang Q; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Qiu DK; Hua J
    World J Gastroenterol; 2018 Feb; 24(6):737-743. PubMed ID: 29456412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD.
    Gawrieh S; Vilar-Gomez E; Wilson LA; Pike F; Kleiner DE; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Kowdley KV; Hameed B; Tonascia J; Loomba R; Sanyal AJ; Chalasani N;
    J Hepatol; 2024 Oct; 81(4):600-608. PubMed ID: 38762169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
    Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    John BV; Khakoo NS; Schwartz KB; Aitchenson G; Levy C; Dahman B; Deng Y; Goldberg DS; Martin P; Kaplan DE; Taddei TH
    Am J Gastroenterol; 2021 Sep; 116(9):1913-1923. PubMed ID: 33989225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.
    Cristoferi L; Calvaruso V; Overi D; Viganò M; Rigamonti C; Degasperi E; Cardinale V; Labanca S; Zucchini N; Fichera A; Di Marco V; Leutner M; Venere R; Picciotto A; Lucà M; Mulinacci G; Palermo A; Gerussi A; D'Amato D; Elisabeth O'Donnell S; Cerini F; De Benedittis C; Malinverno F; Ronca V; Mancuso C; Cazzagon N; Ciaccio A; Barisani D; Marzioni M; Floreani A; Alvaro D; Gaudio E; Invernizzi P; Carpino G; Nardi A; Carbone M;
    Hepatology; 2021 Sep; 74(3):1496-1508. PubMed ID: 33724515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
    Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
    J Hepatol; 2024 Jul; 81(1):23-32. PubMed ID: 38428644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation.
    Montano-Loza AJ; Lytvyak E; Hirschfield G; Hansen BE; Ebadi M; Berney T; Toso C; Magini G; Villamil A; Nevens F; Van den Ende N; Pares A; Ruiz P; Terrabuio D; Trivedi PJ; Abbas N; Donato MF; Yu L; Landis C; Dumortier J; Dyson JK; van der Meer AJ; de Veer R; Pedersen M; Mayo M; Manns MP; Taubert R; Kirchner T; Belli LS; Mazzarelli C; Stirnimann G; Floreani A; Cazzagon N; Russo FP; Burra P; Zigmound U; Houri I; Carbone M; Mulinacci G; Fagiuoli S; Pratt DS; Bonder A; Schiano TD; Haydel B; Lohse A; Schramm C; Rüther D; Casu S; Verhelst X; Beretta-Piccoli BT; Robles M; Mason AL; Corpechot C;
    J Hepatol; 2024 Oct; 81(4):679-689. PubMed ID: 38821360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis.
    Rigamonti C; Cittone MG; Manfredi GF; De Benedittis C; Paggi N; Baorda F; Di Benedetto D; Minisini R; Pirisi M
    JHEP Rep; 2024 Jan; 6(1):100952. PubMed ID: 38192539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
    Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
    Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M;
    J Hepatol; 2024 Jul; 81(1):76-83. PubMed ID: 38521170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
    Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
    J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Goet JC; Murillo Perez CF; Harms MH; Floreani A; Cazzagon N; Bruns T; Prechter F; Dalekos GN; Verhelst X; Gatselis NK; Lindor KD; Lammers WJ; Gulamhusein A; Reig A; Carbone M; Nevens F; Hirschfield GM; van der Meer AJ; van Buuren HR; Hansen BE; Parés A;
    Am J Gastroenterol; 2021 Jul; 116(7):1514-1522. PubMed ID: 33941746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.